Ignelzi Troy A.
CIK 0001579829
Chief Financial OfficerDirector
Filings
16
Latest Apr 6, 2026
Issuers covered
5
Showing
16 of 16
Page 1
Track record
2 of 19 open-market trades scored (11% price coverage) - 17 issuers without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 2 | 0% | -4.6% | -4.6% | -1.8% | -7.5% |
| 90 days | 2 | 100% | +26.1% | +26.1% | +31.5% | +20.8% |
| 180 days | 2 | 100% | +197.1% | +197.1% | +214.4% | +179.7% |
| 365 days | 2 | 100% | +182.1% | +182.1% | +186.4% | +177.8% |
Issuers
Companies where Ignelzi Troy A. has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| KRTX | Karuna Therapeutics, Inc. | 7 | Aug 24, 2023 |
| RAPP | Rapport Therapeutics, Inc. | 4 | Feb 4, 2026 |
| CTNM | Contineum Therapeutics, Inc. | 3 | Jun 26, 2025 |
| CINC | Cincor Pharma, Inc. | 1 | Feb 24, 2023 |
| HRMY | Harmony Biosciences Holdings, Inc. | 1 | Apr 6, 2026 |
All filings
16 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|